Last reviewed · How we verify
NCT05291728
Screening for Early Gastric Cancer in Shaanxi Province
trial in Early Gastric Cancer in 12,500,000 participants. Currently enrolling.
1 October 2026
Quick facts
| Lead sponsor | Second Affiliated Hospital of Xi'an Jiaotong University |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 12,500,000 |
| Start date | 1 October 2020 |
| Primary completion | 1 October 2026 |
| Estimated completion | 1 October 2026 |
| Sites | 1 location across China |
Conditions studied
- Early Gastric Cancer — all drugs for Early Gastric Cancer →
Sponsor
Second Affiliated Hospital of Xi'an Jiaotong University
Who can join
20 and older, any sex, with Early Gastric Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study collect the relevant data of local residents over 20 years old in 11 regions of Shaanxi Province, The basic information of the subjects was collected by filling in the questionnaire, and serum helicobacter pylori antibody detection was completed at the same time. The expert group determined the high-risk population of gastric cancer after comprehensive evaluation. All the high-risk population of gastric cancer without contraindications underwent electronic gastroscopy in the designated hospital after signing the informed consent. By collecting and analyzing data, early gastric cancer screening was completed and a new gastric cancer risk assessment model was established to evaluate the prevalence of dyspepsia, gastroesophageal reflux disease and precancerous lesions in the natural population of Shaanxi Province, as well as helicobacter pylori infection, radical treatment and recurrence rate.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05291728
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Early Gastric Cancer
Currently open trials in the same condition.
- NCT07253948 — Distribution Characteristics of Helicobacter Pylori · recruiting
- NCT06962293 — Magnetic Guided Counetrtraction During Endoscopic Submucosal Dissection · NA · recruiting
- NCT06748352 — Safety and Efficacy of Traction Robot-assisted Endoscopic Submucosal Dissection for Early Gastric Cancer · NA · recruiting
- NCT06788548 — Fluorescence Guided Laparoscopic-Endoscopic Cooperative Sentinel Lymph Node Navigation Surgery Strategy for Early Gastri · NA · recruiting
- NCT05323929 — The Relationship Between Scar Formation and ESD Depth in Therapy for Gastric Carcinoma · NA · recruiting
Other Second Affiliated Hospital of Xi'an Jiaotong University trials
Trials by the same sponsor.
- NCT07160361 — Exploration of Postoperative Adjuvant Therapy for HCC Patients With Positive TB · Phase 4 · not yet recruiting
- NCT07346456 — Comparison of IOL Formulas in Eyes With PCE≥15µm · completed
- NCT06998589 — Comparison of the Efficacy and Safety of Delicate Pulsed Light and Q-Switched 1064 nm Nd:YAG Laser in the Treatment of P · NA · completed
- NCT07305675 — Effectiveness of a rhGM-CSF-containing Gel on Promoting Recovery After 1927-nm Fractional Thulium Fiber Laser Treatment · NA · completed
- NCT06791005 — A Clinical Study on the Benefits of Carbon Nanoparticles Injection Time in Patients With Thyroid Cancer. · Phase 3 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05291728 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Second Affiliated Hospital of Xi'an Jiaotong University
- Last refreshed: 23 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05291728.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing